Pseudoephedrine, Ephedrine Security Subject Of Upcoming DEA Rule
This article was originally published in The Tan Sheet
Executive Summary
The Drug Enforcement Administration expects to issue a proposed rule in June requiring pseudoephedrine, ephedrine and phenylpropanolamine handlers to follow certain security measures, according to the agency's 1"unified agenda" published in the Dec. 3 Federal Register
You may also be interested in...
OTC Distribution Channels Break Out With Prison Bureau Proposed Rule
Prison inmates will have expanded access to over-the-counter drug products under a Bureau of Prisons proposed rule published in the March 1 Federal Register.
OTC pseudoephedrine, PPA "ordinary" products subject to retail reporting threshold by DEA.
OTC PSEUDOEPHEDRINE, PPA "ORDINARY" PRODUCT RETAIL REPORTING THRESHOLD established under proposed implementing regulations to the Comprehensive Methamphetamine Control Act issued by the Drug Enforcement Administration and published in the Federal Register Oct. 7. Under the 1996 law, "ordinary" pseudoephedrine or phenylpropanolamine (PPA) products were exempt from the 24 g single transaction sales reporting trigger required for non-"ordinary" products. "Ordinary" products are defined in the act as those sold in packages not exceeding 3 g pseudoephedrine or PPA base and packaged in blister packs containing no more than two dosage units per blister.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC